eLife 2026年6月8日 Uncoupling the TFIIH Core and Kinase Modules leads to misregulated RNA polymerase II CTD Serine 5 phosphorylation
eLife 2026年6月8日 Membrane binding controls the ATPase cycle and localization of MinD in <i>Bacillus subtilis</i>
eLife 2026年6月8日 Brain-wide arousal signals are segregated from movement planning in the superior colliculus of the macaque
eLife 2026年6月8日 Transcriptional responses to chronic oxidative stress require cholinergic activation of G-protein-coupled receptor signaling
eLife 2026年6月8日 Characterization and modulation of human insulin degrading enzyme conformational dynamics to control enzyme activity
eLife 2026年6月8日 A comprehensive mechanosensory connectome reveals a somatotopically organized neural circuit architecture controlling stimulus-aimed grooming of the <i>Drosophila</i> head
NINGBO YONGXIN OPTICS CO., LTD. 2026年6月7日 World Microscope Objectives - Market Analysis, Forecast, Size, Trends and Insights - IndexBox
Endpoints News 2026年6月7日 #ADA26: 19% of Phase 3 patients quit Boehringer obesity shot over side effects
Illumina 2026年6月7日 Illumina (ILMN) Valuation Check After New Oncology Collaborations And MRD Research Launch - Yahoo Finance
GCC 2026年6月7日 GCC Laboratory Automation Workstations - Market Analysis, Forecast, Size, Trends and Insights - IndexBox
Novo Nordisk 2026年6月7日 Wegovy® pill prescriptions surpass 3 million, 1 filled roughly every 5 seconds, bringing GLP-1 therapy to people with obesity previously untreated, while Novo Nordisk unveils new data at ADA 2026 - PR Newswire
MACHEREY-NAGEL GmbH & Co. KG 2026年6月7日 World Cellulose-Based Chromatography Media - Market Analysis, Forecast, Size, Trends and Insights - IndexBox
Fritsch GmbH 2026年6月7日 Crushing and Pulverizing Equipment Market Forecast Points Higher Toward 2035, Driven by Infrastructure and Critical Mineral Demand - News and Statistics - IndexBox
Schrödinger 2026年6月7日 Scientists finally complete Schrödinger’s 100-year-old color theory - ScienceDaily
FierceBiotech 2026年6月7日 ADA: Tolerability ‘not to be underappreciated’ in Roche, Zealand’s amylin obesity prospect
Roche Media 2026年6月7日 ADA: Tolerability ‘not to be underappreciated’ in Roche, Zealand’s amylin obesity prospect - Fierce Biotech